Michael & Susan Dell Foundation’s Alaunos Therapeutics TCRT Stock Holding History

Michael & Susan Dell Foundation’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-445	Closed	-$202K	–	6
2018 Q2	$202K	Hold	445	–	–	0.29%	6
2018 Q1	$262K	Hold	445	–	–	0.41%	5
2017 Q4	$276K	Hold	445	–	–	0.18%	7
2017 Q3	$410K	Hold	445	–	–	0.32%	7
2017 Q2	$415K	Hold	445	–	–	0.33%	7
2017 Q1	$423K	Hold	445	–	–	0.36%	7
2016 Q4	$357K	Hold	445	–	–	0.27%	7
2016 Q3	$376K	Hold	445	–	–	0.38%	7
2016 Q2	$366K	Hold	445	–	–	0.38%	7
2016 Q1	$495K	Sell	445 -119	-21%	-$122K	0.48%	8
2015 Q4	$703K	Hold	564	–	–	0.6%	7
2015 Q3	$763K	Hold	564	–	–	0.56%	9
2015 Q2	$1.02M	Buy	+564	New	+$876K	0.58%	9

Other funds holding TCRT

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Michael & Susan Dell Foundation's TCRT Position: Q3 2018 in Review

Michael & Susan Dell Foundation sold out of Alaunos Therapeutics (TCRT) in Q3 2018, closing a stake of 445 shares — an estimated $202K sold.

Michael & Susan Dell Foundation first reported a position in TCRT in Q2 2015 and held it in 13 quarters. The position peaked at $1.02M in Q2 2015. 131 funds tracked by Wall St. Rank hold TCRT as of Q3 2018.

Michael & Susan Dell Foundation reported no remaining Alaunos Therapeutics position as of Q3 2018 after selling out during the quarter.
Michael & Susan Dell Foundation sold 445 Alaunos Therapeutics shares in Q3 2018, an estimated $202K.
Michael & Susan Dell Foundation first reported a position in Alaunos Therapeutics in Q2 2015 and held it in 13 quarters.
Michael & Susan Dell Foundation's Alaunos Therapeutics position peaked at $1.02M in Q2 2015.
131 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2018.

Based on Michael & Susan Dell Foundation's 13F filing for Q3 2018, filed 14 Nov 2018.